These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 12817439)
41. A Comparison of Toll-Like Receptor 5 and 21 Ligands as Adjuvants for a Formaldehyde Inactivated H9N2 Avian Influenza Virus Vaccine in Chickens. Astill J; Alkie T; Yitbarek A; Taha-Abdelaziz K; Shojadoost B; Petrik JJ; Nagy É; Sharif S Viral Immunol; 2018 Nov; 31(9):605-612. PubMed ID: 30222508 [TBL] [Abstract][Full Text] [Related]
42. Avian pathogenic Escherichia coli (APEC). Dho-Moulin M; Fairbrother JM Vet Res; 1999; 30(2-3):299-316. PubMed ID: 10367360 [TBL] [Abstract][Full Text] [Related]
43. Assessing cellulitis pathogenicity of Escherichia coli isolates in broiler chickens assessed by an in vivo inoculation model. Jeffrey JS; Chin RP; Singer RS Avian Dis; 1999; 43(3):491-6. PubMed ID: 10494418 [TBL] [Abstract][Full Text] [Related]
44. Enhanced humoural and cellular immune responses to influenza H7N9 antigen HA1-2 fused with flagellin in chickens. Song L; Xiong D; Hu M; Kang X; Pan Z; Jiao X BMC Vet Res; 2017 Jun; 13(1):190. PubMed ID: 28637471 [TBL] [Abstract][Full Text] [Related]
45. Occurrence of the temperature-sensitive hemagglutinin among avian Escherichia coli. Delicato ER; de Brito BG; Konopatzki AP; Gaziri LC; Vidotto MC Avian Dis; 2002; 46(3):713-6. PubMed ID: 12243538 [TBL] [Abstract][Full Text] [Related]
46. Protection capability of recombinant plasmid DNA vaccine containing VP2 gene of very virulent infectious bursal disease virus in chickens adjuvanted with CpG oligodeoxynucleotide. Mahmood MS; Siddique M; Hussain I; Khan A; Mansoor MK Vaccine; 2006 May; 24(22):4838-46. PubMed ID: 16600440 [TBL] [Abstract][Full Text] [Related]
47. Characterization of Immune Responses to an Inactivated Avian Influenza Virus Vaccine Adjuvanted with Nanoparticles Containing CpG ODN. Singh SM; Alkie TN; Abdelaziz KT; Hodgins DC; Novy A; Nagy É; Sharif S Viral Immunol; 2016 Jun; 29(5):269-75. PubMed ID: 27077969 [TBL] [Abstract][Full Text] [Related]
48. Immunoprotection induced by CpG-ODN/Poly(I:C) combined with recombinant gp90 protein in chickens against reticuloendotheliosis virus infection. Yuan F; Chu Y; Qi L; Li H; Sun S; Zhao P; Chang S; Guo H Antiviral Res; 2017 Nov; 147():1-10. PubMed ID: 28465147 [TBL] [Abstract][Full Text] [Related]
49. Chickens hyperimmunized with Escherichia coli J5 strain are protected against experimental challenge with Escherichia coli O78 serotype. Abdul-Aziz TA; el-Sukhon SN Vet Res Commun; 1998 Jan; 22(1):7-9. PubMed ID: 9541985 [No Abstract] [Full Text] [Related]
50. Studies on cellulitis and other disease syndromes caused by Escherichia coli in broilers in Sri Lanka. Gomis SM; Gomis AI; Horadagoda NU; Wijewardene TG; Allan BJ; Potter AA Trop Anim Health Prod; 2000 Dec; 32(6):341-51. PubMed ID: 11147273 [TBL] [Abstract][Full Text] [Related]
51. Use of a modified bacterial ghost lysis system for the construction of an inactivated avian pathogenic Escherichia coli vaccine candidate. Hu J; Zuo J; Chen Z; Fu L; Lv X; Hu S; Shi X; Jing Y; Wang Y; Wang Z; Mi R; Huang Y; Liu D; Qi K; Han X Vet Microbiol; 2019 Feb; 229():48-58. PubMed ID: 30642598 [TBL] [Abstract][Full Text] [Related]
52. Construction and evaluation of a delta cya delta crp Salmonella typhimurium strain expressing avian pathogenic Escherichia coli O78 LPS as a vaccine to prevent airsacculitis in chickens. Roland K; Curtiss R; Sizemore D Avian Dis; 1999; 43(3):429-41. PubMed ID: 10494411 [TBL] [Abstract][Full Text] [Related]
53. Examination of the effects of virus inactivation methods on the induction of antibody- and cell-mediated immune responses against whole inactivated H9N2 avian influenza virus vaccines in chickens. Astill J; Alkie T; Yitbarek A; Taha-Abdelaziz K; Bavananthasivam J; Nagy É; Petrik JJ; Sharif S Vaccine; 2018 Jun; 36(27):3908-3916. PubMed ID: 29853199 [TBL] [Abstract][Full Text] [Related]
55. Applications in in ovo technology. Johnston PA; Liu H; O'Connell T; Phelps P; Bland M; Tyczkowski J; Kemper A; Harding T; Avakian A; Haddad E; Whitfill C; Gildersleeve R; Ricks CA Poult Sci; 1997 Jan; 76(1):165-78. PubMed ID: 9037703 [TBL] [Abstract][Full Text] [Related]
56. Systemic and mucosal antibody responses to selected cell surface antigens of avian pathogenic Escherichia coli in experimentally infected chickens. Kariyawasam S; Wilkie BN; Hunter DB; Gyles CL Avian Dis; 2002; 46(3):668-78. PubMed ID: 12243531 [TBL] [Abstract][Full Text] [Related]
57. Co-stimulation with TLR3 and TLR21 ligands synergistically up-regulates Th1-cytokine IFN-γ and regulatory cytokine IL-10 expression in chicken monocytes. He H; Genovese KJ; Swaggerty CL; MacKinnon KM; Kogut MH Dev Comp Immunol; 2012 Apr; 36(4):756-60. PubMed ID: 22120532 [TBL] [Abstract][Full Text] [Related]
58. Recombinant Iss as a potential vaccine for avian colibacillosis. Lynne AM; Kariyawasam S; Wannemuehler Y; Johnson TJ; Johnson SJ; Sinha AS; Lynne DK; Moon HW; Jordan DM; Logue CM; Foley SL; Nolan LK Avian Dis; 2012 Mar; 56(1):192-9. PubMed ID: 22545546 [TBL] [Abstract][Full Text] [Related]
59. Microsatellite markers associated with quantitative trait loci controlling antibody response to Escherichia coli and Salmonella enteritidis in young broilers. Yunis R; Heller ED; Hillel J; Cahaner A Anim Genet; 2002 Dec; 33(6):407-14. PubMed ID: 12464014 [TBL] [Abstract][Full Text] [Related]
60. A cyclophosphamide-sensitive cell compartment is essential for homologous protection conferred by licensed vaccines for the control of avian pathogenic Escherichia coli in chickens. Sadeyen JR; Kaiser P; Stevens MP; Dziva F Vaccine; 2015 Jul; 33(31):3624-7. PubMed ID: 26087298 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]